Cilostazol
-
Catalog number2393-25
-
Price373.19 USD
-
Size25 mg
-
-
Alternative_name6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
-
DescriptionCilostazol is a clinically approved phosphodiesterase III (PDE3) inhibitor (IC₅₀ = 0.2 µM) and anti-thrombotic agent. It inhibits platelet aggregation and is a direct arterial vasodilator.
-
CAS Number73963-72-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₀H₂₇N₅O₂
-
Molecular Weight369.46
-
Cell PermeableNo
-
Purity≥98% by TLC
-
SolubilitiesDMSO (~20 mg/ml)
-
HandlingProtect from light and air
-
Tag LineA phosphodiesterase 3 (PDE3) inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD00866780
-
PubChem CID2754
-
SMILESC1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
-
InChiInChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)
-
InChi KeyRRGUKTPIGVIEKM-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameCilostazol
-
Alternative nameCilostazol
-